June 21 (Reuters) - Generation Bio Co GBIO.O :
* GENERATION BIO - WILL SEEK TO SUBLEASE PLANNED GMP
FACILITY, AND
WILL ADOPT A MORE CAPITAL EFFICIENT, MODULAR, AND FLEXIBLE
MANUFACTURING APPROACH
* GENERATION BIO - PROJECTS SMALLER GMP MANUFACTURING
FOOTPRINT,
ENABLED BY FURTHER PROCESS DEVELOPMENT OF RAPID ENZYMATIC
SYNTHESIS OF CEDNA AT SCALE
* GENERATION BIO CO - CAPITAL REALLOCATED FROM FACILITY
BUILDOUT
EXPECTED TO EXTEND CASH RUNWAY INTO 2025
* GENERATION BIO - CHANGE IN MANUFACTURING STRATEGY NOT
EXPECTED
TO AFFECT PRODUCTION OF CEDNA FOR ONGOING RESEARCH ON LIVER,
RETINA & VACCINE PROGRAMS
Source text for Eikon: ID:nGNX44KcCq
Further company coverage: GBIO.O
((Reuters.Briefs@thomsonreuters.com;))